Diana Otto

Institution: Basilea Pharmaceutica


Basilea Pharmaceutica International Ltd. Grenzacherstrasse 487 PO Box 4005 Basel Switzerland

Email: diana.otto@basilea.com

Group website: www.basilea.com

Phone: +41 61 606 1365

Research interests:

Cancer Biology Drug discovery and development

Selected publications:

Note publications under maiden name: Diana Perez-Madrigal 1) ERK5 is a critical mediator of inflammation-driven cancer. Finegan KG, Perez-Madrigal D, Hitchin JR, Davies CC, Jordan AM, Tournier C. Cancer Res. 2015 Feb 15;75(4):742-53. 2) The extracellular-regulated protein kinase 5 (ERK5) promotes cell proliferation through the down-regulation of inhibitors of cyclin dependent protein kinases (CDKs).Perez-Madrigal D, Finegan KG, Paramo B, Tournier C. Cell Signal. 2012 Dec;24(12):2360-8

Members List